News Digest / Ticker: CADL

Ticker: CADL

09:15am, Thursday, Aug 14, 2025

Candel reports Phase 3 win, GAAP profit from warrant revaluation; cash runway into Q1 2027

Snapshot - Candel Therapeutics, Inc. (NASDAQ: CADL) What's happening inside the company (quick summary) - Cash-rich for now: management reports cash & cash equivalents of about $100.7 million at June 30, 2025 and expects funding into Q1 2027. - Clinical progress driving expense but also value: po...

09:03am, Tuesday, May 13, 2025

Candel Therapeutics Reports Financial Recovery Amid Ongoing Challenges in Cancer Immunotherapy Development

07:54am, Wednesday, Dec 11, 2024

Candel Therapeutics Stock Soars 150% After Groundbreaking Prostate Cancer Trial Results